Utah Senate approves substitute medical cannabis bill, removes central-fill pharmacy and creates regional cannabis pharmacies

The Utah Senate on Sept. 12, 2019, passed the first substitute to Senate Bill 1002, a package of technical and implementation changes to the state's medical cannabis program that replaces a proposed state central‑fill pharmacy with a phased network of regional cannabis pharmacies and clarifies several patient-protection and licensing provisions.

Senator Vickers, the bill sponsor, said the substitute removes the state central‑fill model and instead directs the Department of Health to issue one request for proposals for 14 cannabis-only pharmacies to be licensed in phases — eight to be licensed by March 2020 and six more by July 2020, subject to available applicants and regional distribution across four quadrants. "The biggest item... is removing the state central fill pharmacy and replacing it with additional retail private pharmacies," Senator Vickers said during floor remarks.

Why it matters: The change was framed as an operational fix to make medication available to patients by March 1, 2020, and to address vendor cost, implementation expertise and local‑government concerns tied to a single central facility. Sponsors said the phased approach balances patient access, market viability and the need to avoid overloading early licensees.

Key provisions and clarifications - Central‑fill removal and regional pharmacies: The bill deletes the state central‑fill pharmacy model and authorizes a single RFP for up to 14 regional cannabis pharmacies, phased as 8 (by March) and 6 (by July) and regionally distributed to ensure statewide access. Department of Health licensing criteria and market demand will guide allocations. - Patient protections and supply: The substitute clarifies that medical cannabis will be treated analogously to other controlled substances in court and regulatory contexts and standardizes the allowed supply at up to 30 days for all patients regardless of distance from a pharmacy. - Courier delivery and signature requirement: Some cannabis pharmacies may contract with a Department of Health courier program to deliver medication to a patient's home; deliveries must be signed for by the patient or an identified caregiver with photo ID (no unattended drop-offs). - Background checks and licensing: The bill allows the Department of Health and the Department of Agriculture to bypass a background check requirement for cardholders reapplying within one year. It also permits licensed academic institutions to be licensed for cultivation/research and clarifies indoor/outdoor cultivation layering for production accounting. - Banking and payment processors: Recognizing federal restrictions and cash concerns, the bill establishes a vetting role for the Department of Finance and the state treasurer to review private payment processors; vetted companies could contract with pharmacies to provide card-like services. - Sunset and conflict limits: A provision restricting license issuance when a legislator has ownership interest remains and includes a sunset date (noted in debate as January 2023).

Debate and concerns Opponents and cautious supporters raised concerns about rural access, price and public‑safety enforcement. Senator Hilliard noted that many of his constituents voted against Proposition 2 and asked whether the bill's changes would keep the program focused on medical patients. He also raised questions about impaired driving enforcement and the absence of a widely accepted roadside test for cannabis impairment. Senator Vickers repeatedly emphasized that the substitute treats medical cannabis "the same way we would any other controlled substance" and that enforcement and impairment determinations remain law‑enforcement responsibilities.

Questions about pricing and rural delivery surfaced in floor exchanges: senators asked whether courier fees or distribution models could make medication more expensive for rural patients. Senator Vickers said the Department of Health would oversee courier contracts and could consider fees in its procurement criteria; price for product at pharmacies was left to market competition among growers, processors and the 14 pharmacies.

Vote and next steps Under suspension of the rules, the Senate voted to read and pass the first substitute to SB1002 by roll call (27 yea, 0 nay, 2 absent). The House subsequently passed the same substitute and transmitted the bill to the Senate for the president's signature and enrollment.

What comes next: With both chambers' passage recorded in the special session, the measure proceeded to enrollment and signature steps required to become law.

Speakers quoted in this article are members of the Utah State Senate as recorded in the session transcript.